Fred Hutch, Seattle Cancer Care Alliance, and UW Medicine Complete Restructure of Partnership

Learn More

Program Tracks

Overview

Most fellows in our program pursue training to fulfill eligibility for certification in both hematology and medical oncology. We prepare our trainees to pursue successful, life-long careers in academic medicine. Our program is designed with these goals in mind, but we can tailor training tracks to those fellows interested in single-board certification or participating in the ABIM Research Pathway. We also offer a special training pathway in classical hematology.

Hematology-Oncology Track

Most fellows in our program dual-board in hematology and oncology and intend to pursue careers in academic medicine. Our program is designed with these goals in mind, but we can tailor training tracks to those fellows interested in single-boarding or participating in the ABIM Research Pathway.

  • Dual-board fellows will complete 18 months of clinical rotations across our training sites with a roughly even mix of inpatient and outpatient experiences and a balanced exposure to the breadth of malignant and hematologic conditions.

  • Halfway through their second year of training, dual-board fellows transition to 24 months of fully funded, mentored research. After three years of training (18 months clinical and 18 months research), fellows will have met all ACGME requirements for graduation and transition to “non-ACGME” status to complete the last six months of their funded research.

  • Single-board fellows in medical oncology complete 12 months of clinical rotations instead of 18 and their curriculum is focused on solid tumors and hematologic malignancy, including blood and marrow transplantation and immunotherapy. At the end of year one, single-board fellows transition to 24 months of funded research. At the end of the first year of research, the ACGME-required portion of training is complete and fellows then transition to non-ACGME status for their second year of research and final year with our program.

  • The above criteria also apply to fellows participating in the ABIM Research Pathway, but they complete 36 months of funded research (instead of 24 months) along with an ongoing continuity clinic after completing their fulltime clinical rotations.

  • All fellows maintain one half-day of continuity clinic per week for the duration of their ACGME training: (a) two years for single-board fellows; (b) three years for dual-board fellows; and (c) at least four years for ABIM Research Pathway fellows. In addition to this required half-day, fellows focusing on a clinical research pathway may also add targeted clinical experiences to gain desired experience in different areas. Continuity clinic is optional for fellows after they transition to non-ACGME status.

Hematology Track

Our program is proud to be one of nine participants in the American Society of Hematology’s Hematology-Focused Fellowship Training Program (HFFTP). Applicants to our program who are interested in single-board certification in hematology should inquire about applying to this track.

  • Single-board fellows in hematology complete 12 months of clinical rotations and their curriculum is focused on non-malignant and malignant hematologic conditions, including blood and marrow transplantation and cell-based immunotherapy, as well as transfusion medicine.

  • After completing their clinical rotations, single-board fellows in hematology embark on 24 months of mentored research. At the end of their first year of research, they will have met all ACGME requirements for graduation, so they transition to non-ACGME status for their second year of research and final year with our program. Fellows view this dedicated research time as a valuable opportunity to transition into academic careers.

  • Fellows pursuing single-board eligibility in hematology will maintain a continuity clinic for one half-day per week during their two years as ACGME fellows. During the research phase of training, they can pursue focused, elective clinical experiences and/or targeted clinics, which may complement their research activities. During their final year of training and research as non-ACGME fellows, clinical work is optional. 

  • As an ASH HFFTP awardee, our program has created four innovative, scholarly pathways for participating fellows:
    • Transfusion medicine and cell therapy 
    • Marrow failure
    • Thrombosis and hemostasis
    • Systems-based hematology